🔎 Trials Near Me

Home › Cataract › NCT07325188

HUD Surgical Guidance for Toric Alignment

Recruiting

Clinical Evaluation of a Novel Intraoperative Guidance System for Accurate Toric IOL Positioning in Cataract Surgery

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion criteria:

* Patients undergoing uncomplicated cataract surgery with toric IOL implantation,
* Eyes implanted with a toric IOL.

Exclusion criteria:

* Ocular comorbidity likely to impair postoperative visual acuities, or
* History of ocular trauma or zonular instability, or
* Previous refractive surgery, or
* Irregular corneal astigmatism or keratoconus, or
* Patients with physical or intellectual disabilities that may prevent reliable fixation or comprehension (e.g. Down's Syndrome, Parkinson's Disease), or
* Patients with unreliable biometry measurements, or
* Severe dry eye disease or ocular surface disease.

About the study

This study aims to assess the accuracy of toric intraocular lens (IOL) alignment axes as calculated and displayed by a novel digital guidance system. In addition, it evaluates the time required to initiate surgical guidance and postoperative refractive astigmatism following toric IOL implantation.

This single-surgeon, single-site, prospective, non-invasive observational study evaluated the accuracy of toric IOL alignment axes calculated and displayed by the digital guidance system (Cassini Technologies, B.V.) in 100 eyes. The intraoperatively calculated alignment axes were compared to preoperative measurements to assess their accuracy (in degrees). Postoperative outcomes, including residual refractive astigmatism (diopters) and visual acuity (Snellen), were recorded at 1 month postoperatively.

What is being tested

Sponsor: Gainesville Eye Associates · Participants: 100 · Started: Nov 4, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07325188

Locations in the U.S.

GeorgiaNorth Georgia Eye Associates, Gainesville

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.